Musculoskeletal Diseases  >>  Cubicin (daptomycin)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cubicin (daptomycin) / Merck (MSD)
NCT03426761: Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections

Completed
4
41
US
Dalbavancin, Dalvance, Xydalba, Zevan, Vancomycin, Daptomycin, Nafcillin, Cefazolin
Infectious Diseases Physicians, Inc., Johns Hopkins University
Bone Infection, Osteomyelitis, Septic Arthritis, Joint Infection, Prosthetic Joint Infection
12/22
12/22

Download Options